Archives of Physical Medicine and Rehabilitation
Volume 87, Issue 8 , Pages 1073-1078 , August 2006

Suicidal Ideation in Multiple Sclerosis

  • Aaron P. Turner, PhD

      Affiliations

    • VA Puget Sound Health Care System, Seattle, WA
    • Department of Rehabilitation Medicine, University of Washington, Seattle, WA
    • Corresponding Author InformationReprint requests to Aaron P. Turner, PhD, VA Puget Sound Health Care System, Rehabilitation Care Services, S-117, 1660 S Columbian Way, Seattle, WA 98108
    • ,
  • Rhonda M. Williams, PhD

      Affiliations

    • VA Puget Sound Health Care System, Seattle, WA
    • Department of Rehabilitation Medicine, University of Washington, Seattle, WA
    • ,
  • James D. Bowen, MD

      Affiliations

    • VA Puget Sound Health Care System, Seattle, WA
    • Department of Neurology, University of Washington, Seattle, WA
    • ,
  • Daniel R. Kivlahan, PhD

      Affiliations

    • VA Puget Sound Health Care System, Seattle, WA
    • Department of Psychiatry and Behavioral Sciences, University of Washington, Seattle, WA
    • ,
  • Jodie K. Haselkorn, MD, MPH

      Affiliations

    • VA Puget Sound Health Care System, Seattle, WA
    • Department of Rehabilitation Medicine, University of Washington, Seattle, WA

References 

  1. Lucchinetti C , Bruck W , Rodriguez M , Lassmann H . Distinct patterns of multiple sclerosis pathology indicates heterogeneity on pathogenesis . Brain Pathol . 1996;6:259–274
  2. McDonald WI , Compston A , Edan G , et al.   Recommended diagnostic criteria for multiple sclerosis (guidelines from the International Panel on the Diagnosis of Multiple Sclerosis) . Ann Neurol . 2001;50:121–127
  3. Noseworthy J , Lucchinetti C , Rodriguez M , Weinshenker BG . Multiple sclerosis . N Engl J Med . 2000;343:938–952
  4. Reingold SC . Prevalence estimates for MS in the United States and evidence of an increasing trend for women . Neurology . 2002;59:294; author reply 294-5
  5. Aronson K . Quality of life among persons with multiple sclerosis and their caregivers . Neurology . 1996;48:74–80
  6. Goodkin DE . The natural history of multiple sclerosis . New York: Springer-Verlag; 1992;
  7. Williams RM , Turner AP , Hatzakis M , Bowen JD , Rodriquez AA , Haselkorn JK . Prevalence and correlates of depression among veterans with multiple sclerosis . Neurology . 2005;64:75–80
  8. Minden SL , Orav J , Reich P . Depression in multiple sclerosis . Gen Hosp Psychiatry . 1987;9:426–434
  9. Siegert R , Abernethy D . Depression in multiple sclerosis (a review) . J Neurol Neurosurg Psychiatry . 2006;76:469–475
  10. Sadovnick AD , Eisen K , Ebers GC , Paty DW . Cause of death in patients attending multiple sclerosis clinics . Neurology . 1991;41:1193–1196
  11. Stenager EN , Stenager E , Koch-Henriksen N , et al.   Suicide and multiple sclerosis (an epidemiological investigation) . J Neurol Neurosurg Psychiatry . 1992;55:542–545
  12. Fredrikson S , Cheng Q , Jiang GX , Wasserman D . Elevated suicide risk among patients with multiple sclerosis in Sweden . Neuroepidemiology . 2003;22:146–152
  13. Fisk JD , Morehouse SA , Brown MG , Skedgel C , Murray TJ . Hospital-based psychiatric service utilization and morbidity in multiple sclerosis . Can J Neurol Sci . 1998;25:230–235
  14. Stenager EN , Koch-Henriksen N , Stenager E . Risk factors for suicide in multiple sclerosis . Psychother Psychosom . 1996;65:86–90
  15. Anderson RN , Kochanek KD , Murphy SL . Report of final mortality statistics . Hyattsville: National Center for Health Statistics; 1997;
  16. Stenager EN , Stenager E . Suicide and patients with neurologic diseases. Methodologic problems . Arch Neurol . 1992;49:1296–1303
  17. Goldstein RB , Black DW , Nasrallah A , Winokur G . The prediction of suicide. Sensitivity, specificity, and predictive value of a multivariate model applied to suicide among 1906 patients with affective disorders . Arch Gen Psychiatry . 1991;48:418–422
  18. Kessler RC , Berglund P , Borges G , Nock M , Wang PS . Trends in suicide ideation, plans, gestures, and attempts in the United States, 1990-1992 to 2001-2003 . JAMA . 2005;293:2487–2495
  19. Kessler RC , Borges G , Walters EE . Prevalence of and risk factors for lifetime suicide attempts in the National Comorbidity Survey . Arch Gen Psychiatry . 1999;56:617–626
  20. Feinstein A . An examination of suicidal intent in patients with multiple sclerosis . Neurology . 2002;59:674–678
  21. Luoma JB , Martin CE , Pearson JL . Contact with mental health and primary care providers before suicide (a review of the evidence) . Am J Psychiatry . 2002;159:909–916
  22. Patten SB , Metz LM  SPECTRIMS Study Group . Interferon beta1a and depression in secondary progressive MS (data from the SPECTRIMS trial) . Neurology . 2002;59:744–746
  23. Mohr D , Goodkin D . Treatment of depression in multiple sclerosis (review and meta-analysis) . Clin Psychol . 1999;6:1–9
  24. Wallin MT , Wilken JA , Turner AP , Williams RM , Kane R . Depression and multiple sclerosis (review of a lethal combination) . J Rehabil Res Dev . 2006;43:45–61
  25. U.S. Preventive Service Task Force . Screening for depression (recommendations and rationale) . Rockville: Agency for Healthcare Research and Quality; 2002; May
  26. Spitzer RL , Kroenke K , Williams JB . Validation and utility of a self-report version of PRIME-MD: the PHQ primary care study. Primary Care Evaluation of Mental Disorders. Patient Health Questionnaire . JAMA . 1999;282:1737–1744
  27. Kroenke K , Spitzer RL , Williams JB . The PHQ-9 (validity of a brief depression severity measure) . J Gen Intern Med . 2001;16:606–613
  28. Diagnostic and statistical manual of mental disorders . 4th ed.. Washington (DC): American Psychiatric Association; 1994;
  29. Williams JW , Noel PH , Cordes JA , Ramirez G , Pignone M . Is this patient clinically depressed? . JAMA . 2002;287:1160–1170
  30. Sherbourne CD , Stewart AL . The MOS social support survey . Soc Sci Med . 1991;32:705–714
  31. Schwartz CE , Vollmer T , Lee H  North American Research Consortium on Multiple Sclerosis Outcomes Study Group . Reliability and validity of two self-report measures of impairment and disability for MS . Neurology . 1999;52:63–70
  32. Vollmer TL , Ni W , Stanton S , Hadjimichael O . The NARCOMS patient registry (a resource for investigators) . Int J MS Care . 1999;1:12–15
  33. Corson K , Gerrity MS , Dobscha SK . Screening for depression and suicidality in a VA primary care setting (2 items are better than 1 item) . Am J Manag Care . 2004;10(11 Pt 2):839–845
  34. Berman A , Samuels L . Suicide among people with multiple sclerosis . J Neurol Rehabil . 1993;7:53–62
  35. Beck AT , Steer RA , Kovacs M , Garrison B . Hopelessness and eventual suicide (a 10-year prospective study of patients hospitalized with suicidal ideation) . Am J Psychiatry . 1985;142:559–563
  36. Patten SB , Metz LM . Hopelessness ratings in relapsing-remitting and secondary progressive multiple sclerosis . Int J Psychiatry Med . 2002;32:155–165
  37. Bongar B . The suicidal patient (clinical and legal standards of care) . Washington (DC): American Psychological Association; 1991;
  38. Weissman MM , Bland RC , Canino GJ , et al.   Prevalence of suicide ideation and suicide attempts in nine countries . Psychol Med . 1999;29:9–17
  39. Rich CL , Warstadt GM , Nemiroff RA , Fowler RC , Young D . Suicide, stressors, and the life cycle . Am J Psychiatry . 1991;148:524–527
  40. Moscicki EK . Identification of suicide risk factors using epidemiologic studies . Psychiatr Clin North Am . 1997;20:499–517
  41. Lana-Peixoto MA , Teixeira AL , Haase VG . Interferon beta-1a-induced depression and suicidal ideation in multiple sclerosis . Arq Neuropsiquiatr . 2002;60(3-B):721–724
  42. Klapper JA . Interferon beta treatment of multiple sclerosis . [letter] Neurology . 1994;44:188
  43. Conwell Y , Duberstein PR , Caine ED . Risk factors for suicide in later life . Biol Psychiatry . 2002;52:193–204
  44. Gaynes BN , West SL , Ford CA , Frame P , Klein J , Lohr KN . Screening for suicide risk in adults (a summary of the evidence for the U.S. Preventive Services Task Force) . Ann Intern Med . 2004;140:822–835
  45. Schiffer R , Wineman N . Antidepressant pharmacotherapy of depression associated with multiple sclerosis . Am J Psychiatry . 1990;147:1493–1497
  46. Mohr D , Boudewyn A , Goodkin D , Bostrom A , Epstein L . Comparative outcomes for individual cognitive-behavior therapy, supportive-expressive group psychotherapy, and sertraline for the treatment of depression in multiple sclerosis . J Consult Clin Psychol . 2001;69:942–949
  47. Crawford J , McIvor G . Stress management for multiple sclerosis patients . Psychol Rep . 1987;61:423–429
  48. Larcombe N , Wilson P . An evaluation of cognitive-behaviour therapy for depression in patients with multiple sclerosis . Br J Psychiatry . 1984;145:366–371
  49. Foley FW , Bedell JR , LaRocca NG , Scheinberg LC , Reznikoff M . Efficacy of stress-inoculation training in coping with multiple sclerosis . J Consult Clin Psychol . 1987;55:919–922
  50. Mohr D , Likosky W , Bertagnolli A , et al.   Telephone-administered cognitive-behavioral therapy for the treatment of depressive symptoms in multiple sclerosis . J Consult Clin Psychol . 2000;68:356–361

 Supported by the Department of Veterans Affairs VISN 20, the Department of Veterans Affairs (award no. B3319VA), the VA Center of Excellence in Multiple Sclerosis, and the VA Center of Excellence in Substance Abuse Treatment and Education.No commercial party having a direct financial interest in the results of the research supporting this article has or will confer a benefit upon the author(s) or upon any organization with which the author(s) is/are associated.

PII: S0003-9993(06)00405-9

doi: 10.1016/j.apmr.2006.04.021

Archives of Physical Medicine and Rehabilitation
Volume 87, Issue 8 , Pages 1073-1078 , August 2006

Article Tools